Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Quanzhou Fortune Biopharma is an active Chinese pharmaceutical company specializing in contract synthesis, production of pharmaceutical intermediates, APIs, food additives, PEG derivatives (including polydisperse and monodisperse), lipids for LNPs, amino acids, plant extracts, healthcare supplements. It operates research centers and manufacturing bases across China with ISO9001-certified quality systems. Its main markets are North America, Europe, Japan, South Korea, India and the Middle East. It collaborates closely with academic institutions on new technology R&D. The company does not develop proprietary drugs but provides key materials used in drug development/manufacturing by others.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Quanzhou Fortune Biopharma.